HSP90AA1 and myeloid sarcoma: Tumor protein P53 (TP53), serine/threonine-protein kinase AKT (AKT1), epidermal growth factor receptor (EGFR), estrogen receptor 1 (ESR1), jun proto-oncogene (JUN), sarcoma gene (SRC), and HSP90AA1 in the PPI network had higher values, suggesting that they may be central targets of the BHDH Decoction in the treatment of MS.